{"id":465599,"title":"Avis d'admissibilité pour Opdivo (203286) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"fr","captureDate":"2026-01-05","captureTimestamp":"2026-01-05T06:12:18.342000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/avis-conformite/conditions/avis-admissibilite-opdivo-189307.html","snippet":"Avis d'admissibilité pour Opdivo (203286) Direction des médicaments biologiques et radiopharmaceutiques 100, promenade Eglantine Immeuble du LLCM Pré Tunney, I.A. 0601C Ottawa ON K1A 0K9 Numéro de dossier: HC6-024-E177442 Numéro de contrôle: 203286 Numéro de document : 1265369…","rawSnapshotUrl":"/api/snapshots/raw/465599","browseUrl":"https://replay.healtharchive.ca/job-6/20260105061218/https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/avis-conformite/conditions/avis-admissibilite-opdivo-189307.html#ha_snapshot=465599","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}